Relationship Between Atrial Fibrillation with Rapid Ventricular Response and Leukocytosis
Atrial fibrillation with rapid ventricular response (AFib RVR) does not directly cause worsening leukocytosis, but rather, an elevated white blood cell count is more likely to be a marker of underlying inflammation that can both trigger AFib and worsen its clinical course. 1
Pathophysiological Connection Between AFib and Inflammation
Inflammatory Mechanisms in AFib
- Lymphomononuclear inflammatory infiltrates are commonly found in atrial biopsies from patients with AFib 1
- Increased neutrophil/lymphocyte ratio, a marker of inflammation, is associated with the occurrence of postoperative AFib 1
- Inflammatory markers (C-reactive protein, interleukin-1β, 2,6,8, and TNF-α) are elevated in patients with or at increased risk of AFib 1
How Inflammation Affects Cardiac Electrophysiology
Inflammation may induce or promote AFib through two primary mechanisms:
Direct effects on cardiac electrophysiology:
- Dysregulation of intracellular Ca²⁺ handling
- Enhanced RyR2-mediated sarcoplasmic reticulum Ca²⁺ release
- Alteration of ion channel function by inflammatory mediators
- Reduction in cardiac Na⁺ channels and gap junction proteins 1
Indirect effects through structural remodeling:
- Promotion of atrial fibrosis
- Conduction disturbances that create a substrate for AFib 1
Hemodynamic Consequences of AFib RVR
AFib RVR can lead to significant hemodynamic compromise through several mechanisms:
Loss of synchronous atrial contraction - particularly important in patients with impaired diastolic ventricular filling 1, 2
Irregular ventricular response - studies show that irregular ventricular stimulation results in a 9-15% reduction in cardiac output compared to regular stimulation at the same mean frequency 1, 2
Rapid heart rate - persistently elevated ventricular rate (≥130 bpm) can produce:
The Bidirectional Relationship
The relationship between AFib RVR and inflammatory markers appears bidirectional:
Inflammation as a trigger for AFib:
AFib RVR as a stressor:
Clinical Implications
When encountering a patient with both AFib RVR and leukocytosis:
Consider underlying causes:
Management priorities:
Common Pitfalls
Misattribution of causality: Assuming AFib RVR is directly causing leukocytosis rather than both being manifestations of an underlying inflammatory process 1
Overlooking tachycardia-induced cardiomyopathy: Failure to recognize that persistent AFib RVR can lead to reversible ventricular dysfunction 1, 2
Inappropriate management: Using rate control agents contraindicated in specific situations (e.g., calcium channel blockers in heart failure patients with AFib RVR) 6
In conclusion, while AFib RVR does not directly cause worsening leukocytosis, both conditions often coexist due to shared inflammatory pathways. When treating patients with both conditions, focus on identifying and addressing the underlying inflammatory trigger while providing appropriate rate control for the AFib RVR.